Physician profile
Natalia Alejandro
NPI 1104019496
$669.25
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $213 · 2021: $154 · 2022: $169.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $254.41 | 2020-2021 | |
| Pfizer INC. | $73.26 | 2019-2022 | |
| Allergan, INC. | $71.05 | 2019-2020 | |
| Exeltis, USA INC. | $64.56 | 2021-2022 | |
| Abbvie INC. | $46.58 | 2021-2022 | |
| Therapeuticsmd, INC. | $28.54 | 2019-2020 | |
| Avion Pharmaceuticals | $27.53 | 2019-2021 | |
| Medtronic, INC. | $19.51 | 2022 | |
| Ethicon US, LLC | $17.95 | 2022 | |
| Kci USA, INC. | $14.76 | 2019 | |
| Organon LLC | $14.37 | 2022 | |
| Duchesnay USA Incorporated | $13.28 | 2019 | |
| Meditrina | $12.43 | 2020 | |
| Minerva Surgical, INC | $11.02 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Research and ownership
$149.16 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalia Alejandro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.